Randox Lipase (Colorimetric) Product Usage: A lipase test system is a device intended to measure the activity of the enzyme lipase in serum and plasma. Lipase measurements are used in the diagnosis and treatment of diseases of the pancreas such as acute pancreatitis and obstruction of the pancreatic duct.
This recall has been terminated (originally issued October 18, 2016).
- Recall Initiated
- August 2, 2016
- Posted
- October 18, 2016
- Terminated
- September 7, 2017
- Recall Number
- Z-0123-2017
- Quantity
- 18
- Official Source
- View on FDA website ↗
Reason for Recall
According to the firm carry over was observed when the Lipase test is run directly before or after the LDL and Triglycerides assays. Customers are instructed to amend the running order for all instruments using these reagents to ensure Lipase is not place directly before or after LDL or Triglycerides. A correction was made to the IFU for the Lipase assay and all customers who purchased the Lipase kit in the USA were contacted with the updated instruction.
Distribution
US Nationwide Distribution
Lot / Code Info
Catalogue number: LI3837, LI7979, LI8050, LI8361
Root Cause
Nonconforming Material/Component
Action Taken
Randex Laboratories sent an Urgent Field Safety Notice letter dated June 17, 2016 to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to complete and return the response section of this form technical.services@randox.com. For questions contact Randex Technical Service.